CDTX vs GNRC · rev $1.3M vs P/E 82, rev $4.21B
Cidara Therapeutics Inc (CDTX) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported GNRC revenue for 2025-12-31 was $4.21B. Net income was $159.6M. Revenue was down 2.0% from 2024-12-31 to 2025-12-31. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
CDTX currently screens at market cap $6.96B. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the CDTX and GNRC stock pages for the full models.
Not investment advice.